Argent BioPharma (ASX:RGT) requested a trading halt for its shares pending a disclosure to be made by the company regarding a capital raise, according to a Friday filing with the Australian bourse.
The shares will remain in a trading halt until the announcement is made or the start of normal trading on Jan. 7 or upon the release of the disclosure, the filing said.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。